What a load of rubbish. Go and have a look at their clinical results from the trial. They exceed the outcomes from chemo alone. Full stop.
The oversight committee was somehow reviewing OSL product to a different criteria or parameters that were agreed upon with BSI. This misunderstanding/oversight will be corrected soon when they get together and have the meeting.
When they finally get CE Mark approval for their product what will you say then. And what about the FDA. Would they have given a green light to a much bigger trial if the product was not effective?
You have had it in for the company for a long time. It is obvious. You don’t own any stock and yet you find yourself posting on this site more times than anyone who has skin in the game. Don’t figure.
OSL Price at posting:
5.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)